Literature DB >> 25896179

Testicular cancer: Optimal management of stage I seminoma in 2015.

Guy C Toner1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25896179     DOI： 10.1038/nrurol.2015.85

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  10 in total

1.  Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19/EORTC 30982 study (ISRCTN27163214).

Authors:  R Timothy D Oliver; Graham M Mead; Gordon J S Rustin; Johnathan K Joffe; Nina Aass; Robert Coleman; Rhian Gabe; Philip Pollock; Sally P Stenning
Journal:  J Clin Oncol       Date:  2011-01-31       Impact factor: 44.544

2.  Optimal management of clinical stage I testis cancer: one size does not fit all.

Authors:  Ronald de Wit; George J Bosl
Journal:  J Clin Oncol       Date:  2013-09-03       Impact factor: 44.544

3.  Active surveillance is the preferred approach to clinical stage I testicular cancer.

Authors:  Craig R Nichols; Bruce Roth; Peter Albers; Lawrence H Einhorn; Richard Foster; Siamak Daneshmand; Michael Jewett; Padraig Warde; Christopher J Sweeney; Clair Beard; Tom Powles; Scott Tyldesley; Alan So; Christopher Porter; Semra Olgac; Karim Fizazi; Brandon Hayes-Lattin; Peter Grimison; Guy Toner; Richard Cathomas; Carsten Bokemeyer; Christian Kollmannsberger
Journal:  J Clin Oncol       Date:  2013-09-03       Impact factor: 44.544

4.  A nationwide cohort study of stage I seminoma patients followed on a surveillance program.

Authors:  Mette Saksø Mortensen; Jakob Lauritsen; Maria Gry Gundgaard; Mads Agerbæk; Niels Vilstrup Holm; Ib Jarle Christensen; Hans von der Maase; Gedske Daugaard
Journal:  Eur Urol       Date:  2014-07-23       Impact factor: 20.096

5.  Second cancers among 40,576 testicular cancer patients: focus on long-term survivors.

Authors:  Lois B Travis; Sophie D Fosså; Sara J Schonfeld; Mary L McMaster; Charles F Lynch; Hans Storm; Per Hall; Eric Holowaty; Aage Andersen; Eero Pukkala; Michael Andersson; Magnus Kaijser; Mary Gospodarowicz; Timo Joensuu; Randi J Cohen; John D Boice; Graça M Dores; Ethel S Gilbert
Journal:  J Natl Cancer Inst       Date:  2005-09-21       Impact factor: 13.506

Review 6.  Surveillance vs. adjuvant therapy of clinical stage I testicular tumors - a review and the SWENOTECA experience.

Authors:  G Cohn-Cedermark; O Stahl; T Tandstad
Journal:  Andrology       Date:  2014-10-01       Impact factor: 3.842

7.  Risk-adapted treatment in clinical stage I testicular seminoma: the third Spanish Germ Cell Cancer Group study.

Authors:  Jorge Aparicio; Pablo Maroto; Xavier García del Muro; Josep Gumà; Alfonso Sánchez-Muñoz; Mireia Margelí; Montserrat Doménech; Romá Bastús; Antonio Fernández; Marta López-Brea; Josefa Terrassa; Andrés Meana; Purificación Martínez del Prado; Javier Sastre; Juan J Satrústegui; Regina Gironés; Lidia Robert; José R Germà
Journal:  J Clin Oncol       Date:  2011-10-31       Impact factor: 44.544

Review 8.  Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer.

Authors:  J Oldenburg; J Aparicio; J Beyer; G Cohn-Cedermark; M Cullen; T Gilligan; U De Giorgi; M De Santis; R de Wit; S D Fosså; J R Germà-Lluch; S Gillessen; H S Haugnes; F Honecker; A Horwich; A Lorch; D Ondruš; G Rosti; A J Stephenson; T Tandstad
Journal:  Ann Oncol       Date:  2014-11-06       Impact factor: 32.976

9.  Treatment preferences in stage IA and IB testicular seminoma: multicenter study of Anatolian Society of Medical Oncology.

Authors:  Ahmet Bilici; Turkan Ozturk; Esma Turkmen; Hatice Odabas; Sener Cihan; Fatih Selcukbiricik; Bulent Erdogan; Zurat Urakci; Nurten Kandemir; Ibrahim Vedat Bayoglu; Umut Demirci; Ayse Ocak Duran; Mehmet Ali Nahit Sendur; Dilek Yavuzer; Hakan Harputluoglu; Halil Kavgaci; Mahmut Gumus
Journal:  World J Urol       Date:  2015-01-21       Impact factor: 4.226

10.  Evaluation of a prognostic model for risk of relapse in stage I seminoma surveillance.

Authors:  Peter Chung; Gedske Daugaard; Scott Tyldesley; Eshetu G Atenafu; Tony Panzarella; Christian Kollmannsberger; Padraig Warde
Journal:  Cancer Med       Date:  2014-09-19       Impact factor: 4.452
  10 in total
  2 in total

1.  Controversies in the management of clinical stage I testicular seminoma.

Authors:  Martina Ondrusova; Sona Balogova; Viera Lehotska; Karol Kajo; Bela Mrinakova; Dalibor Ondrus
Journal:  Cent European J Urol       Date:  2016-01-20

2.  Decrease in radiation therapy rates in patients with stage I seminoma: a population-based study.

Authors:  Shi Jia; Jingping Qiu
Journal:  Transl Cancer Res       Date:  2021-01       Impact factor: 1.241
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.